Abductor Reattachment Methods in Proximal Femur Replacements: What is the Best Method?
Launched by DUKE UNIVERSITY · Aug 23, 2017
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying different methods of attaching the abductor muscles in patients who are having a part of their thigh bone (proximal femur) replaced due to conditions like sarcoma or bone metastases. The researchers want to find out if attaching these muscles directly to the new prosthesis (the artificial part) leads to better movement and function after surgery. They also aim to create a simple and affordable way to check how well the abductor muscles are working during follow-up visits using regular X-rays.
To be part of this study, participants need to be scheduled for a proximal femur replacement surgery performed by an orthopedic oncologist. However, those who were unable to walk before or after the surgery, or who might not be able to attend follow-up appointments, will not be included. If eligible, participants can expect to be monitored closely after their surgery to see how well they recover and regain function. The trial is currently recruiting and welcomes individuals of all ages.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Has undergone or is scheduled for proximal femur replacement by an Ortho Oncology surgeon
- Exclusion Criteria:
- • Non-ambulatory before or after the procedure
- • Subjects who, in the opinion of the investigator, have not or likely will not complete at least some portion of the investigator's recommended follow-up
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Patients applied
Trial Officials
William Eward, MD, DVM
Principal Investigator
Duke University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials